Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Hydroflumethiazide measurement |
Component |
True |
Hydroflumethiazide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing hydroflumethiazide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydroflumethiazide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Hydroflumethiazide adverse reaction (disorder) |
Causative agent (attribute) |
True |
Hydroflumethiazide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to hydroflumethiazide (finding) |
Causative agent (attribute) |
False |
Hydroflumethiazide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely hydroflumethiazide 50 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydroflumethiazide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely hydroflumethiazide 25 milligram and spironolactone 25 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydroflumethiazide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hydroflumethiazide 50 mg and spironolactone 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydroflumethiazide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing hydroflumethiazide and spironolactone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydroflumethiazide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Allergy to hydroflumethiazide (finding) |
Causative agent (attribute) |
True |
Hydroflumethiazide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Hydroflumethiazide 50 mg and spironolactone 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydroflumethiazide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Hydroflumethiazide 50 mg and spironolactone 50 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Hydroflumethiazide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely hydroflumethiazide 50 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydroflumethiazide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely hydroflumethiazide 50 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Hydroflumethiazide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely hydroflumethiazide 25 milligram and spironolactone 25 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hydroflumethiazide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely hydroflumethiazide 25 milligram and spironolactone 25 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Hydroflumethiazide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely hydroflumethiazide 25 milligram and spironolactone 25 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Hydroflumethiazide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely hydroflumethiazide 50 milligram/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Hydroflumethiazide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Hydroflumethiazide 50 mg and spironolactone 50 mg oral tablet |
Has precise active ingredient |
True |
Hydroflumethiazide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing hydroflumethiazide and spironolactone in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydroflumethiazide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing hydroflumethiazide in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydroflumethiazide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only hydroflumethiazide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydroflumethiazide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Hydroflumethiazide and spironolactone only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydroflumethiazide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only hydroflumethiazide and spironolactone in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydroflumethiazide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only hydroflumethiazide in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Hydroflumethiazide (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |